Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin

Hepatology

Volumn 47, Issue 5, 2008, Pages 1544-1556

  Komuta, Mina ^a,b,e   Spee, Bart ^a,c   Borght, Sara Vander ^a   De Vos, Rita ^a   Verslype, Chris ^a   Aerts, Raymond ^a   Yano, Hirohisa ^b   Suzuki, Tetsuya ^d   Matsuda, Masanori ^d   Fujii, Hideki ^d   Desmet, Valeer J ^a   Kojiro, Masamichi ^b   Roskams, Tania ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e Laboratory of Morphology and Molecular Pathology   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARCINOEMBRYONIC ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 7; LEUKEMIA INHIBITORY FACTOR; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 3; NERVE CELL ADHESION MOLECULE; STEM CELL FACTOR RECEPTOR; TUMOR MARKER; ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; CYTOKERATIN 19; HEPATOCYTE PARAFFIN 1; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 3; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL; MALE; PRIORITY JOURNAL; STEM CELL; TUMOR VOLUME; CLINICAL FEATURE; GENE EXPRESSION PROFILING; HEPATIC PROGENITOR CELL; HUMAN TISSUE; LIVER CELL CARCINOMA;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER GLYCOGEN; MALE; MICROSCOPY, ELECTRON; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; RNA, NEOPLASM; STEM CELLS;

EID: 43949123310     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22238     Document Type: Article

References (28)

1. Steiner PE, Higginson J. Cholangiolocellular carcinoma of the liver. Cancer 1959;12:753-759.
2. Hirohashi S, Ishak K, Kojiro M, Wanless I, Theise N, Tsukuma H, et al. Tumours of the liver and intrahepatic bile ducts. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000:157-202.
3. Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, BioulacSage P, et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. HEPATOLOGY 2004;39:1739-1745.
4. Roskams T, De Vos R, Van Eyken P, Myazaki H, Van Damme B, Desmet V. Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J Hepatol 1998;29:455-463.
5. Roskams TA, Libbrecht L, Desmet VJ. Progenitor cells in diseased human liver. Semin Liver Dis 2003;23:385-396.
6. Theise ND, Saxena R, Portmann BC, Thung SN, Yee H, Chiriboga L, et al. The canals of Heting and hepatic stem cells in humans. HEPATOLOGY 1999;30:1425-1433.
7. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006;25:3818-3822.
8. Roskams T. Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus. J Hepatol 2003;39:431-434.
9. Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006;49:138-151.
10. Uenishi T, Kubo S, Yamamoto T, Shuto T, Ogawa M, Tanaka H, et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early post-operative recurrence. Cancer Sci 2003;94:851-857.
11. Wu PC, Fang JW, Lau VK, Lai CL, Lo CK, Lau JY. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol 1996;149:1167-1175.
12. Tanaka S, Yamamoto T, Tanaka H, Kodai S, Ogawa M, Ichikawa T, et al. Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell: Immunohistochemical evidence. Hepatol Res 2005;32:52-57.
13. Nomoto K, Tsuneyama K, Cheng C, Takahashi H, Hori R, Murai Y, et al. Intrahepatic cholangiocarcinoma arising in cirrhotic liver frequently expressed p63-positive basal/stem-cell phenotype. Pathol Res Pract 2005;202:71-76.
14. Libbrecht L, Desmet V, Van Damme B, Roskams T. The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J Hepatol 2000;33:76-84.
15. Libbrecht L, De Vos R, Cassiman D, Desmet V, Aerts R, Roskams T. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol 2001;25:1388-1396.
16. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006;12:410-416.
17. Crosby HA, Kelly DA, Strain AJ. Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium. Gastroenterology 2001;120:534-544.
18. Yin S, Li J, Hu C, Chen X, Yao M, Yan M, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 2007;120:1444-1450.
19. Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005;26:495-502.
20. Trosko JE. From adult stem cells to cancer stem cells: Oct-4 gene, cell-cell communication, and hormones during tumor promotion. Ann N Y Acad Sci 2006;1089:36-58.
21. Znoyko I, Sohara N, Spicer SS, Trojanowska M, Reuben A. Expression of oncostatin M and its receptors in normal and cirrhotic human liver. J Hepatol 2005;43:893-900.
22. Ros JE, Libbrecht L, Geuken M, Jansen PL, Roskams TA. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease. J Pathol 2003;200:553-560.
23. Vander Borght S, Libbrecht L, Katoonizadeh A, van Pelt J, Cassiman D, Nevens F, et al. Breast cancer resistance protein (BCRP/ABCG2) is expressed by progenitor cells/reactive ductules and hepatocytes and its expression pattern is influenced by disease etiology and species type: possible functional consequences. J Histochem Cytochem 2006;54:1051-1059.
24. Shiota K, Taguchi J, Nakashima O, Nakashima M, Kojiro M. Clinicopathologic study on cholangiolocellular carcinoma. Oncol Rep 2001;8:263-268.
25. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. HEPATOLOGY 1994;19:1513-1520.
26. De Vos R, Desmet V. Ultrastructural characteristics of novel epithelial cell types identified in human pathologic liver specimens with chronic ductular reaction. Am J Pathol 1992;140:1441-1450.
27. Takanishi K, Miyazaki M, Ohtsuka M, Nakajima N. Inverse relationship between P-glycoprotein expression and its proliferative activity in hepatocellular carcinoma. Oncology 1997;54:231-237.
28. Shimoda M, Kubota K. Multi-disciplinary treatment for cholangiocellular carcinoma. World J Gastroenterol 2007;13:1500-1504.